Publication scheme

NHS Cornwall and Isles of Scilly has followed guidance from the Information Commissioner and adopted the healthcare publication scheme.

The scheme helps people access information about us, the decisions we make and how we spend public money.

The pages below will provide you with information on:

Most of the information we produce is available on our website. However, some may be in hard copy only. You can also check if the information you are looking for is in our disclosure log. The disclosure log contains responses to all the freedom of information requests we have received.

Prescribing rebate scheme

NHS Cornwall and Isles of Scilly has a policy to agree and consider future prescribing rebates. The arrangements for the drugs are listed below. Information correct as of 14 April 2022.

Attention deficit hyperactivity disorder

Product: Xaggitin

Company: Ethypharm.

Type: For use in the treatment of attention deficit hyperactivity disorder (ADHD).

Start date: 1 August 2017.

End date: Rolling.

Aligned to PrescQIPP: Yes.

Anti-psychotic medicine

Product: Quetiapine Biquelle

Company: Aspire Pharma Limited.

Type: Atypical anti-psychotic medicine.

Start date: 1 April 2022.

End date: 31 March 2023.

Aligned to PrescQIPP: Yes.

Product: Zaluron XL (Quetiapine XL)

Company: Fontus Health Limited.

Type: Anti-psychotic medicine.

Start date: 1 August 2019.

End date: 30 July 2024.

Aligned to PrescQIPP: Yes.

Emollient for eczema

Product: Balneum

Company: Almirall Limited.

Type: Emollient for eczema.

Start date: 23 June 2020.

End date: 22 June 2022.

Aligned to PrescQIPP: Yes.

Inhalers

Product: Clenil Modulite

Company: Chiesi Limited.

Type: Inhaler.

Start date: 1 August 2021.

End date: 31 July 2023.

Aligned to PrescQIPP: Yes.

Product: Fostair NEXThaler

Company: Chiesi Limited.

Type: Inhaler.

Start date: 1 May 2021.

End date: 30 April 2023.

Aligned to PrescQIPP: Yes.

Product: Fostair pMDI

Company: Chiesi Limited.

Type: Inhaler.

Start date: 1 August 2021.

End date: 31 July 2023.

Aligned to PrescQIPP: Yes.

Product: Sereflo

Company: CIPLA.

Type: Inhaler.

Start date: 1 August 2021.

End date: 31 July 2023.

Aligned to PrescQIPP: Yes.

Insulin

Product: Aprida

Company: Aventis Pharma Limited trading as Sanofi.

Type: Insulin.

Start date: 1 April 2022.

End date: 31 March 2023.

Aligned to PrescQIPP: Yes.

Product: Insuman

Company: Aventis Pharma Limited trading as Sanofi.

Type: Insulin.

Start date: 1 April 2022.

End date: 31 March 2023.

Aligned to PrescQIPP: Yes.

Product: Lispro

Company: Aventis Pharma Limited trading as Sanofi.

Type: Insulin.

Start date: 1 April 2020.

End date: 30 September 2021.

Aligned to PrescQIPP: Yes.

Pain relief

Product: Fencino

Company: DS Ashbourne Limited (Part of the Ethypharm Group).

Type: Pain relief patch.

Start date: 1 April 2016.

End date: Rolling.

Aligned to PrescQIPP: Yes.

Parkinson’s

Product: Pipexus

Company: Ethypharm.

Type: For use in the treatment for Parkinson’s.

Start date: 1 July 2018.

End date: Rolling.

Aligned to PrescQIPP: Yes.

Prostate cancer

Product: Firmagon (degarelix)

Company: Ferring Pharmaceuticals.

Type: For use in the treatment for prostate cancer.

Start date: 1 September 2019.

End date: 31 December 2021.

Aligned to PrescQIPP: Yes.

Page last reviewed: 28 July, 2022

Google Translate

Text Size

Change font

Contrast